Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ACE | P12821 | 3/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7811720 | 1.00 | RAB9A (0.57) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL7815566 | 1.00 | RAB9A (0.57) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL5493674 | 0.95 | RAB9A (0.62) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL695608 | 0.95 | RAB9A (0.62) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL2634067 | 0.95 | RAB9A (0.62) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL9464451 | 0.94 | RAB9A (0.61) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL18209676 | 0.92 | RAB9A (0.58) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL16124534 | 0.91 | RAB9A (0.61) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL9176416 | 0.91 | RAB9A (0.60) | RAB9AL3MBTL1ACEACE2LMNA | |
| SCHEMBL18106053 | 0.90 | RAB9A (0.57) | RAB9AL3MBTL1ACEACE2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022070287-A1 | MACROCYCLE COMPOUND | 旭化成ファーマ株式会社 | 2022-04-07 | — | — | WO | disclosed |
| EP-2844648-B1 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | MERCK PATENT GMBH (DE) | 2016-11-09 | — | — | EP | disclosed |
| EP-2844648-A1 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | Merck Patent GmbH (DE) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013045028-A9 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | MERCK PATENT GMBH (DE) | 2014-12-24 | — | — | WO | disclosed |
| WO-2013045028-A1 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | MERCK PATENT GMBH (DE) | 2013-04-04 | — | — | WO | disclosed |
| WO-2010094977-A1 | NOVEL BIPHENYL COMPOUNDS USEFUL FOR THE TREATMENT OF HEPATITIS C | ARROW THERAPEUTICS LIMITED (GB) | 2010-08-26 | — | — | WO | disclosed |
| EP-0986384-A4 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIV PITTSBURGH (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-0986384-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998050029-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-11-12 | — | — | WO | disclosed |
| EP-0784628-A1 | INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | Vertex Pharmaceuticals Incorporated (US) | 1997-07-23 | — | — | EP | disclosed |
| WO-1995035308-A1 | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1995-12-28 | — | — | WO | disclosed |
| EP-0617705-A4 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. | YEDA RES & DEV (IL) | 1994-12-28 | — | — | EP | disclosed |
| EP-0617705-A1 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. | YEDA RES & DEV (IL) | 1994-10-05 | — | — | EP | disclosed |
| WO-1993009795-A1 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1993-05-27 | — | — | WO | disclosed |